| Randolph W Heisinger, MD | |
|
1104 W 8th St, Yankton, SD 57078-3306 | |
| (605) 665-7841 | |
| (605) 665-0546 |
| Full Name | Randolph W Heisinger |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1104 W 8th St, Yankton, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023019049 | NPI | - | NPPES |
| 6700044 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 1066 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Randolph W Heisinger, MD 1104 W 8th St, Yankton, SD 57078-3306 Ph: (605) 665-7841 | Randolph W Heisinger, MD 1104 W 8th St, Yankton, SD 57078-3306 Ph: (605) 665-7841 |
News Archive
A Science article published on July 9, 2010, describes the discovery of an alternative form of evolution that helps Drosophila flies conquer nematodes that sterilize them. Nematodes are among the most abundant, diverse and destructive parasites of plants and animals.
Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists who met at the NIH State of the Science Symposium in Therapeutic Apheresis. Nora Ratcliffe, MD, of Dartmouth Hitchcock, looked at current methodology and opportunities for research in a paper recently published in Transfusion Medicine Review, titled "National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis."
A combination of umeclidinium and vilanterol is more effective than each drug as monotherapy for the treatment of chronic obstructive pulmonary disease, research indicates.
NicOx S.A. has announced that a new analysis of the data from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study for naproxcinod was presented yesterday at the American Heart Association Scientific Sessions 2008, in New Orleans, USA.
Aeterna Zentaris Inc. today announced that the European Patent Office has granted a patent for the use of alkyl phosphocholines, more specifically perifosine, in the preparation of a medicament for the treatment of benign and malignant tumours, prior to and/or during the treatment with approved anti-tumour anti-metabolites such as 5FU and capecitabine.
› Verified 5 days ago
David W Withrow, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Carroll Isburg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Martha Holstein, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 | |
Dawn M Larson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Dr. April Kay Willman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Sara Pepper, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 |